TEMPO Compounds Mitigate Oxidative Stress in Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address the progressive loss of homeostatic reserve with aging, leading to increased risk of debilitating diseases such as bone fractures, cardiovascular disease, cognitive impairment, diabetes, and cancer, with DNA damage and oxidative stress contributing to aging-related degenerative changes.
Innovation Solution
Administration of compounds containing TEMPO or 4-amino-TEMPOL functional groups, such as XJB-5-131, JP4-039, JED-E71-37, and JED-E71-58, which act as antioxidant and free radical scavengers to inhibit senescence, reduce oxidative stress, and delay age-related diseases by targeting mitochondrial damage and DNA repair mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to address aging, then general health maintenance is provided, but they fail to effectively reduce oxidative stress and DNA damage accumulation
Solution Approach 1:
The patent introduces TEMPO and 4-amino-TEMPOL compounds as intermediary substances that mediate between free radicals (harmful factors) and biological molecules (DNA, proteins, lipids). These compounds act as chain-breaking antioxidants that intercept and neutralize free radicals before they can cause oxidative damage to cellular components, thereby effectively reducing oxidative stress and DNA damage accumulation associated with aging.
Solution Approach 2:
The patent converts the harmful effect of free radicals into a beneficial outcome by using TEMPO and 4-amino-TEMPOL compounds that deliberately undergo oxidation themselves. These compounds sacrifice themselves by reacting with free radicals, converting the harmful oxidative stress into a controlled reaction that protects cellular components. The compounds act as decoys that absorb oxidative damage, thereby protecting DNA, proteins, and lipids from harm.
2Duration of action of stationary object
If aging is allowed to progress naturally, then chronological age increases, but homeostatic reserve is progressively lost leading to increased disease risk
Solution Approach 1:
The patent applies preliminary action by administering TEMPO and 4-amino-TEMPOL compounds before significant oxidative damage and loss of homeostatic reserve occur. These compounds are given continuously or periodically to prevent oxidative stress accumulation and DNA damage before they reach critical thresholds that would trigger aging-related diseases. This preventive approach maintains homeostatic reserve throughout the aging process rather than treating damage after it occurs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds delay the onset and progression of age-related symptoms, improve healthspan, and reduce oxidative damage, demonstrating potential in treating aging-related disorders and degenerative diseases by effectively targeting cellular and mitochondrial stress.
Implementation Method 1
compounds containing TEMPO or 4-amino-TEMPOL functional groups, such as XJB-5-131, JP4-039, JED-E71-37, and JED-E71-58, which act as antioxidant and free radical scavengers to inhibit senescence, reduce oxidative stress
Data Source
AI summary
The present invention relates to methods of inhibiting one or more signs of aging and/or degenerative disorder in a subject in need of such treatment, which comprise administering, to the subject, an effective amount of one or more of the compounds as set forth herein. “Inhibiting a sign of aging or degenerative disorder” means reducing the risk of occurrence, delaying the onset, slowing the progression, and/or reducing the severity and/or manifestation, of a sign of aging or degenerative disorder, and includes, but is not limited to, preventing the occurrence, development or progression of a sign of aging or degenerative disorder.